Ubunifu wa Majaribio Unaojirekebisha
Ubunifu wa majaribio unaojirekebisha huruhusu marekebisho yaliyobainishwa mapema kwenye jaribio kulingana na data ya muda—kama vile kukadiria upya ukubwa wa sampuli, kusitisha kwa kutokuwa na matokeo au ufanisi, kuacha mikono isiyofaa, au kubadilisha uwiano wa ugawaji nasibu kuelekea matibabu yanayofanya vizuri zaidi. Uliendelezwa kwa utaratibu katika miaka ya 1990–2000 na wanatakwimu kama Pocock na Jennison, na kurasimishwa na FDA mnamo 2019, miundo inayojirekebisha huharakisha uundaji wa dawa, hupunguza mfiduo wa matibabu yasiyofaa, na kuboresha ufanisi bila kuongeza viwango vya chanya za uwongo vinapotekelezwa ipasavyo.
Soma mbinu kamili
Ingia kwa akaunti ya bure ili kusoma sehemu hii.
Ramani ya mbinu
Jirani ya mbinu zinazohusiana — chagua nodi ili kuchunguza.
Vyanzo
- Pocock, S. J. (2005). Current issues in the design and interpretation of clinical trials. BMJ, 330(7500), 1118–1121. link ↗
- Pallmann, P., Bedding, A. W., Choodari-Oskooei, B., Dimairo, M., Flight, L., Hampson, L. V., ... & Wason, J. (2018). Adaptive designs in clinical trials: why use them, and how to run and report them. BMC Medicine, 16(1), 29. DOI: 10.1186/s12916-018-1017-7 ↗
- FDA (2019). Adaptive Designs for Clinical Trials of Drugs and Biologics: Guidance for Industry. US Food and Drug Administration. link ↗
Jinsi ya kunukuu ukurasa huu
ScholarGate. (2026, June 4). Adaptive Clinical Trial Design with Pre-Planned Interim Analyses. ScholarGate. https://scholargate.app/sw/clinical-research/adaptive-trial-design
Mbinu ipi?
Weka mbinu hii kando ya jamaa zake wa karibu na uzisome bega kwa bega — maktaba huweka vitabu mezani; uamuzi ni wako.
- Jaribio Lililodhibitiwa kwa Nasibu (RCT)Muundo wa Majaribio↔ linganisha
Imerejelewa na
Similar methods
Umeona tatizo kwenye ukurasa huu? Ripoti au pendekeza marekebisho →